{"id":30,"date":"2026-07-14T18:10:15","date_gmt":"2026-07-14T18:10:15","guid":{"rendered":"https:\/\/blitzlab.eu\/blog-selank-kaufen\/"},"modified":"2026-10-23T23:36:58","modified_gmt":"2026-10-23T21:36:58","slug":"buy-selank","status":"publish","type":"page","link":"https:\/\/blitzlab.eu\/en\/blog-selank-kaufen\/","title":{"rendered":"Selank kaufen \u2013 Forschungsleitfaden"},"content":{"rendered":"
\n
Home<\/a>\u203a<\/span>Blog<\/a>\u203a<\/span>Buy Selank 2026<\/span><\/div>\n\n

Buy Selank 2026 \u2014 Tuftsin Analogue Heptapeptide for GABA\/Cytokine Research (EU)<\/h1>\n

Peptide Research \u00b7 28 June 2026 \u00b7 11 min read \u00b7 Research Use Only<\/p>\n\n

\n In short:<\/strong> Selank is a synthetic Heptapeptide<\/strong> and a tuftsin analogue (derived from the immune peptide tuftsin). This research guide summarises, the published in-vitro and animal model literature<\/strong> documented for Selank \u2013 from its relationship to Tuftsin via GABAergic models to cytokine\/immune marker models. At BlitzLab as 10mg vial<\/strong> with batch-related Certificate of Analysis (COA)<\/a>, HPLC \u2265 99 %, EU delivery. Price: <\/strong>. For research use only (RUO).\n <\/div>\n
<\/svg> Scientific-factual research guide. Summarises published study observations. No health, dosage or application advice, no statement about suitability in humans. Research Use Only.<\/div>\n\n

Selank at a glance<\/h2>\n \n
Designation<\/th>Selank (Tuftsin Analogue Heptapeptide)<\/td><\/tr>\n
Identity<\/th>Synthetic heptapeptide, Tuftsin analogue (derived from the immunopeptide Tuftsin)<\/td><\/tr>\n
Synonyms<\/th>Tuftsin analogue, TP-7<\/td><\/tr>\n
Research context<\/th>GABAergic models, cytokine\/immune marker models, tuftsin similarity (in vitro\/animal model)<\/td><\/tr>\n
CAS number<\/th>129954-34-3 (the batch-specific COA is authoritative)<\/span><\/td><\/tr>\n
Molecular formula<\/th>See CoA<\/td><\/tr>\n
Form<\/th>Lyophilisate (freeze-dried), white powder, sealed vial<\/td><\/tr>\n
Amount<\/th>10 mg per vial<\/td><\/tr>\n
Purity<\/th>\u226599% (HPLC), identity confirmed by LC-MS<\/td><\/tr>\n
Analysis<\/th>External third-party laboratory, batch-specific COA<\/td><\/tr>\n
Intended use<\/th>For Research Use Only (RUO)<\/td><\/tr>\n
Price<\/th> \u00b7 Shipping from Germany<\/td><\/tr>\n <\/table>\n\n

What is Selank?<\/h2>\n

Selank is a synthetically produced Heptapeptide<\/strong> \u2013 that is, a chain of seven amino acids. It is an analogue of the immune peptide Tuftsin<\/strong>, a naturally occurring peptide of the immune system, and is also referred to in the literature as a Tuftsin analogue and TP-7. Compared with the original Tuftsin, the sequence has been modified so that the molecule is easier to handle and more stable to characterise for research purposes. Selank is supplied as a stable lyophilisate in a sealed vial (10 mg). In laboratory research, it serves as a defined, well-characterised reference substance. The CAS number and molecular formula are documented in the batch-specific certificate of analysis.<\/p>\n\n

Molecular profile & target structure<\/h2>\n

As a short heptapeptide, Selank is structurally derived from the Tuftsin<\/strong>motif \u2013 a peptide fragment long described in biochemistry as an immunopeptide. The defined, short sequence and its similarity to Tuftsin make Selank a frequently used model peptide: it can be produced synthetically and reproducibly and is readily accessible analytically, which makes it suitable as a reference in neurobiological and immunobiological study models. In the research literature, Selank is primarily considered in the context of two subject areas \u2013 the GABAergic systems<\/strong> and from cytokine and immune markers<\/strong> \u2013 in each case exclusively at the level of preclinical models.<\/p>\n\n

What in-vitro and animal model studies document<\/h2>\n

The following summary reflects only what is described in the publicly accessible preclinical literature<\/strong> \u2013 it is not a statement about an effect or suitability in humans.<\/p>\n